nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—epilepsy syndrome	0.434	1	CbGaD
Danazol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0191	0.0879	CbGbCtD
Danazol—CYP3A4—Trimethadione—epilepsy syndrome	0.0177	0.0817	CbGbCtD
Danazol—CYP3A4—Felbamate—epilepsy syndrome	0.0177	0.0817	CbGbCtD
Danazol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0167	0.0768	CbGbCtD
Danazol—CYP3A4—Clonazepam—epilepsy syndrome	0.0151	0.0694	CbGbCtD
Danazol—CYP3A4—Clobazam—epilepsy syndrome	0.0145	0.0666	CbGbCtD
Danazol—CYP3A4—Rufinamide—epilepsy syndrome	0.0123	0.0566	CbGbCtD
Danazol—CYP3A4—Carbamazepine—epilepsy syndrome	0.012	0.0552	CbGbCtD
Danazol—CYP3A4—Primidone—epilepsy syndrome	0.0112	0.0515	CbGbCtD
Danazol—CYP3A4—Phenytoin—epilepsy syndrome	0.0108	0.0495	CbGbCtD
Danazol—CYP3A4—Propofol—epilepsy syndrome	0.01	0.0462	CbGbCtD
Danazol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00958	0.0441	CbGbCtD
Danazol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00958	0.0441	CbGbCtD
Danazol—CYP3A4—Midazolam—epilepsy syndrome	0.00945	0.0435	CbGbCtD
Danazol—CYP3A4—Diazepam—epilepsy syndrome	0.00909	0.0418	CbGbCtD
Danazol—CYP3A4—Zonisamide—epilepsy syndrome	0.00887	0.0408	CbGbCtD
Danazol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00716	0.033	CbGbCtD
Danazol—CYP3A4—Topiramate—epilepsy syndrome	0.00646	0.0297	CbGbCtD
Danazol—GNRHR—hindbrain—epilepsy syndrome	0.00361	0.0931	CbGeAlD
Danazol—GNRHR—brainstem—epilepsy syndrome	0.00207	0.0534	CbGeAlD
Danazol—SHBG—hindbrain—epilepsy syndrome	0.00164	0.0424	CbGeAlD
Danazol—CCL2—forebrain—epilepsy syndrome	0.00156	0.0402	CbGeAlD
Danazol—PGR—hindbrain—epilepsy syndrome	0.00148	0.0382	CbGeAlD
Danazol—CCL2—telencephalon—epilepsy syndrome	0.00143	0.037	CbGeAlD
Danazol—ESR1—hindbrain—epilepsy syndrome	0.00116	0.0299	CbGeAlD
Danazol—GNRHR—head—epilepsy syndrome	0.00114	0.0295	CbGeAlD
Danazol—CCL2—medulla oblongata—epilepsy syndrome	0.00113	0.029	CbGeAlD
Danazol—GNRHR—nervous system—epilepsy syndrome	0.00108	0.028	CbGeAlD
Danazol—GNRHR—central nervous system—epilepsy syndrome	0.00104	0.0269	CbGeAlD
Danazol—CCL2—midbrain—epilepsy syndrome	0.00103	0.0266	CbGeAlD
Danazol—GNRHR—cerebellum—epilepsy syndrome	0.00102	0.0263	CbGeAlD
Danazol—CCL2—spinal cord—epilepsy syndrome	0.001	0.0259	CbGeAlD
Danazol—SHBG—brainstem—epilepsy syndrome	0.000942	0.0243	CbGeAlD
Danazol—CCL2—head—epilepsy syndrome	0.000892	0.023	CbGeAlD
Danazol—CCL2—nervous system—epilepsy syndrome	0.000846	0.0218	CbGeAlD
Danazol—GNRHR—brain—epilepsy syndrome	0.000828	0.0214	CbGeAlD
Danazol—CCL2—central nervous system—epilepsy syndrome	0.000814	0.021	CbGeAlD
Danazol—CCL2—cerebellum—epilepsy syndrome	0.000796	0.0205	CbGeAlD
Danazol—CYP19A1—forebrain—epilepsy syndrome	0.000737	0.019	CbGeAlD
Danazol—ESR1—brainstem—epilepsy syndrome	0.000664	0.0171	CbGeAlD
Danazol—AR—forebrain—epilepsy syndrome	0.000652	0.0168	CbGeAlD
Danazol—CCL2—brain—epilepsy syndrome	0.000647	0.0167	CbGeAlD
Danazol—ESR1—forebrain—epilepsy syndrome	0.00064	0.0165	CbGeAlD
Danazol—AR—telencephalon—epilepsy syndrome	0.0006	0.0155	CbGeAlD
Danazol—ESR1—telencephalon—epilepsy syndrome	0.000589	0.0152	CbGeAlD
Danazol—SHBG—central nervous system—epilepsy syndrome	0.000475	0.0123	CbGeAlD
Danazol—PGR—head—epilepsy syndrome	0.000469	0.0121	CbGeAlD
Danazol—SHBG—cerebellum—epilepsy syndrome	0.000464	0.012	CbGeAlD
Danazol—PGR—nervous system—epilepsy syndrome	0.000445	0.0115	CbGeAlD
Danazol—PGR—central nervous system—epilepsy syndrome	0.000428	0.011	CbGeAlD
Danazol—CYP19A1—head—epilepsy syndrome	0.000422	0.0109	CbGeAlD
Danazol—AR—spinal cord—epilepsy syndrome	0.00042	0.0108	CbGeAlD
Danazol—PGR—cerebellum—epilepsy syndrome	0.000418	0.0108	CbGeAlD
Danazol—CYP19A1—nervous system—epilepsy syndrome	0.0004	0.0103	CbGeAlD
Danazol—CYP19A1—central nervous system—epilepsy syndrome	0.000385	0.00994	CbGeAlD
Danazol—SHBG—brain—epilepsy syndrome	0.000377	0.00973	CbGeAlD
Danazol—AR—head—epilepsy syndrome	0.000374	0.00964	CbGeAlD
Danazol—ESR1—head—epilepsy syndrome	0.000367	0.00946	CbGeAlD
Danazol—AR—nervous system—epilepsy syndrome	0.000354	0.00914	CbGeAlD
Danazol—ESR1—nervous system—epilepsy syndrome	0.000348	0.00897	CbGeAlD
Danazol—AR—central nervous system—epilepsy syndrome	0.000341	0.0088	CbGeAlD
Danazol—PGR—brain—epilepsy syndrome	0.00034	0.00877	CbGeAlD
Danazol—ESR1—central nervous system—epilepsy syndrome	0.000335	0.00864	CbGeAlD
Danazol—Prednisone—SLCO1A2—epilepsy syndrome	0.000332	0.108	CrCbGaD
Danazol—ESR1—cerebellum—epilepsy syndrome	0.000327	0.00844	CbGeAlD
Danazol—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.00031	0.101	CrCbGaD
Danazol—CYP19A1—brain—epilepsy syndrome	0.000306	0.00789	CbGeAlD
Danazol—AR—brain—epilepsy syndrome	0.000271	0.00699	CbGeAlD
Danazol—ESR1—brain—epilepsy syndrome	0.000266	0.00686	CbGeAlD
Danazol—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000234	0.0763	CrCbGaD
Danazol—Cortisone acetate—NR3C1—epilepsy syndrome	0.000214	0.0699	CrCbGaD
Danazol—CYP3A4—nervous system—epilepsy syndrome	0.000194	0.00501	CbGeAlD
Danazol—CYP3A4—central nervous system—epilepsy syndrome	0.000187	0.00482	CbGeAlD
Danazol—Testosterone—SLCO1A2—epilepsy syndrome	0.00018	0.0588	CrCbGaD
Danazol—Ethinyl Estradiol—ABCC2—epilepsy syndrome	0.000163	0.0531	CrCbGaD
Danazol—Testosterone—CYP11A1—epilepsy syndrome	0.000157	0.0512	CrCbGaD
Danazol—Fluoxymesterone—NR3C1—epilepsy syndrome	0.00014	0.0458	CrCbGaD
Danazol—Prednisone—NR3C1—epilepsy syndrome	0.000121	0.0395	CrCbGaD
Danazol—Prednisone—CYP2C19—epilepsy syndrome	0.00011	0.036	CrCbGaD
Danazol—Norethindrone—CYP2C19—epilepsy syndrome	0.000109	0.0355	CrCbGaD
Danazol—Hydrocortisone—ABCG2—epilepsy syndrome	9.88e-05	0.0323	CrCbGaD
Danazol—Dyspepsia—Lamotrigine—epilepsy syndrome	9.57e-05	0.000516	CcSEcCtD
Danazol—Erythema multiforme—Gabapentin—epilepsy syndrome	9.53e-05	0.000514	CcSEcCtD
Danazol—Vertigo—Valproic Acid—epilepsy syndrome	9.51e-05	0.000513	CcSEcCtD
Danazol—Leukopenia—Valproic Acid—epilepsy syndrome	9.47e-05	0.000511	CcSEcCtD
Danazol—Asthenia—Vigabatrin—epilepsy syndrome	9.46e-05	0.00051	CcSEcCtD
Danazol—Urticaria—Clonazepam—epilepsy syndrome	9.42e-05	0.000508	CcSEcCtD
Danazol—Dizziness—Midazolam—epilepsy syndrome	9.39e-05	0.000506	CcSEcCtD
Danazol—Tension—Pregabalin—epilepsy syndrome	9.39e-05	0.000506	CcSEcCtD
Danazol—Body temperature increased—Clonazepam—epilepsy syndrome	9.37e-05	0.000505	CcSEcCtD
Danazol—Fatigue—Lamotrigine—epilepsy syndrome	9.37e-05	0.000505	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	9.36e-05	0.000505	CcSEcCtD
Danazol—Urticaria—Phenytoin—epilepsy syndrome	9.36e-05	0.000505	CcSEcCtD
Danazol—Palpitations—Valproic Acid—epilepsy syndrome	9.35e-05	0.000504	CcSEcCtD
Danazol—Pruritus—Vigabatrin—epilepsy syndrome	9.33e-05	0.000503	CcSEcCtD
Danazol—Asthenia—Diazepam—epilepsy syndrome	9.32e-05	0.000502	CcSEcCtD
Danazol—Body temperature increased—Phenytoin—epilepsy syndrome	9.31e-05	0.000502	CcSEcCtD
Danazol—Urticaria—Oxcarbazepine—epilepsy syndrome	9.31e-05	0.000502	CcSEcCtD
Danazol—Constipation—Lamotrigine—epilepsy syndrome	9.29e-05	0.000501	CcSEcCtD
Danazol—Nervousness—Pregabalin—epilepsy syndrome	9.29e-05	0.000501	CcSEcCtD
Danazol—Nausea—Acetazolamide—epilepsy syndrome	9.28e-05	0.0005	CcSEcCtD
Danazol—Dizziness—Levetiracetam—epilepsy syndrome	9.27e-05	0.0005	CcSEcCtD
Danazol—Body temperature increased—Oxcarbazepine—epilepsy syndrome	9.26e-05	0.000499	CcSEcCtD
Danazol—Back pain—Pregabalin—epilepsy syndrome	9.25e-05	0.000499	CcSEcCtD
Danazol—Vomiting—Propofol—epilepsy syndrome	9.23e-05	0.000498	CcSEcCtD
Danazol—Muscle spasms—Pregabalin—epilepsy syndrome	9.2e-05	0.000496	CcSEcCtD
Danazol—Pruritus—Diazepam—epilepsy syndrome	9.19e-05	0.000495	CcSEcCtD
Danazol—Rash—Propofol—epilepsy syndrome	9.15e-05	0.000493	CcSEcCtD
Danazol—Dermatitis—Propofol—epilepsy syndrome	9.14e-05	0.000493	CcSEcCtD
Danazol—Hypertension—Valproic Acid—epilepsy syndrome	9.13e-05	0.000493	CcSEcCtD
Danazol—Headache—Propofol—epilepsy syndrome	9.09e-05	0.00049	CcSEcCtD
Danazol—Chills—Gabapentin—epilepsy syndrome	9.04e-05	0.000487	CcSEcCtD
Danazol—Vomiting—Midazolam—epilepsy syndrome	9.03e-05	0.000487	CcSEcCtD
Danazol—Asthenia—Felbamate—epilepsy syndrome	9.02e-05	0.000486	CcSEcCtD
Danazol—Vision blurred—Pregabalin—epilepsy syndrome	9.01e-05	0.000486	CcSEcCtD
Danazol—Arthralgia—Valproic Acid—epilepsy syndrome	9.01e-05	0.000486	CcSEcCtD
Danazol—Haematuria—Topiramate—epilepsy syndrome	9e-05	0.000485	CcSEcCtD
Danazol—Anxiety—Valproic Acid—epilepsy syndrome	8.98e-05	0.000484	CcSEcCtD
Danazol—Tremor—Pregabalin—epilepsy syndrome	8.96e-05	0.000483	CcSEcCtD
Danazol—Rash—Midazolam—epilepsy syndrome	8.95e-05	0.000483	CcSEcCtD
Danazol—Dizziness—Fosphenytoin—epilepsy syndrome	8.95e-05	0.000483	CcSEcCtD
Danazol—Dermatitis—Midazolam—epilepsy syndrome	8.95e-05	0.000482	CcSEcCtD
Danazol—Urticaria—Carbamazepine—epilepsy syndrome	8.93e-05	0.000482	CcSEcCtD
Danazol—Vomiting—Levetiracetam—epilepsy syndrome	8.92e-05	0.000481	CcSEcCtD
Danazol—Alopecia—Gabapentin—epilepsy syndrome	8.9e-05	0.00048	CcSEcCtD
Danazol—Headache—Midazolam—epilepsy syndrome	8.9e-05	0.00048	CcSEcCtD
Danazol—Pruritus—Felbamate—epilepsy syndrome	8.89e-05	0.00048	CcSEcCtD
Danazol—Body temperature increased—Carbamazepine—epilepsy syndrome	8.89e-05	0.000479	CcSEcCtD
Danazol—Rash—Levetiracetam—epilepsy syndrome	8.84e-05	0.000477	CcSEcCtD
Danazol—Dermatitis—Levetiracetam—epilepsy syndrome	8.83e-05	0.000476	CcSEcCtD
Danazol—Asthenia—Zonisamide—epilepsy syndrome	8.83e-05	0.000476	CcSEcCtD
Danazol—Headache—Levetiracetam—epilepsy syndrome	8.78e-05	0.000474	CcSEcCtD
Danazol—Dizziness—Vigabatrin—epilepsy syndrome	8.72e-05	0.00047	CcSEcCtD
Danazol—Pruritus—Zonisamide—epilepsy syndrome	8.71e-05	0.000469	CcSEcCtD
Danazol—Oedema—Valproic Acid—epilepsy syndrome	8.63e-05	0.000466	CcSEcCtD
Danazol—Urticaria—Lamotrigine—epilepsy syndrome	8.63e-05	0.000465	CcSEcCtD
Danazol—Nausea—Propofol—epilepsy syndrome	8.62e-05	0.000465	CcSEcCtD
Danazol—Tension—Gabapentin—epilepsy syndrome	8.61e-05	0.000464	CcSEcCtD
Danazol—Vomiting—Fosphenytoin—epilepsy syndrome	8.61e-05	0.000464	CcSEcCtD
Danazol—Vertigo—Pregabalin—epilepsy syndrome	8.59e-05	0.000463	CcSEcCtD
Danazol—Body temperature increased—Lamotrigine—epilepsy syndrome	8.59e-05	0.000463	CcSEcCtD
Danazol—Dizziness—Diazepam—epilepsy syndrome	8.59e-05	0.000463	CcSEcCtD
Danazol—Syncope—Pregabalin—epilepsy syndrome	8.58e-05	0.000463	CcSEcCtD
Danazol—Leukopenia—Pregabalin—epilepsy syndrome	8.56e-05	0.000462	CcSEcCtD
Danazol—Rash—Fosphenytoin—epilepsy syndrome	8.53e-05	0.00046	CcSEcCtD
Danazol—Dermatitis—Fosphenytoin—epilepsy syndrome	8.53e-05	0.00046	CcSEcCtD
Danazol—Hydrocortisone—NR3C1—epilepsy syndrome	8.52e-05	0.0278	CrCbGaD
Danazol—Haemoglobin—Topiramate—epilepsy syndrome	8.52e-05	0.000459	CcSEcCtD
Danazol—Nervousness—Gabapentin—epilepsy syndrome	8.52e-05	0.000459	CcSEcCtD
Danazol—Asthenia—Clonazepam—epilepsy syndrome	8.51e-05	0.000459	CcSEcCtD
Danazol—Back pain—Gabapentin—epilepsy syndrome	8.48e-05	0.000457	CcSEcCtD
Danazol—Headache—Fosphenytoin—epilepsy syndrome	8.48e-05	0.000457	CcSEcCtD
Danazol—Haemorrhage—Topiramate—epilepsy syndrome	8.48e-05	0.000457	CcSEcCtD
Danazol—Thrombocytopenia—Valproic Acid—epilepsy syndrome	8.45e-05	0.000456	CcSEcCtD
Danazol—Palpitations—Pregabalin—epilepsy syndrome	8.45e-05	0.000456	CcSEcCtD
Danazol—Asthenia—Phenytoin—epilepsy syndrome	8.45e-05	0.000456	CcSEcCtD
Danazol—Nausea—Midazolam—epilepsy syndrome	8.43e-05	0.000455	CcSEcCtD
Danazol—Muscle spasms—Gabapentin—epilepsy syndrome	8.43e-05	0.000455	CcSEcCtD
Danazol—Tachycardia—Valproic Acid—epilepsy syndrome	8.43e-05	0.000454	CcSEcCtD
Danazol—Loss of consciousness—Pregabalin—epilepsy syndrome	8.41e-05	0.000453	CcSEcCtD
Danazol—Asthenia—Oxcarbazepine—epilepsy syndrome	8.41e-05	0.000453	CcSEcCtD
Danazol—Pruritus—Clonazepam—epilepsy syndrome	8.39e-05	0.000452	CcSEcCtD
Danazol—Vomiting—Vigabatrin—epilepsy syndrome	8.39e-05	0.000452	CcSEcCtD
Danazol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	8.35e-05	0.00045	CcSEcCtD
Danazol—Pruritus—Phenytoin—epilepsy syndrome	8.33e-05	0.000449	CcSEcCtD
Danazol—Nausea—Levetiracetam—epilepsy syndrome	8.33e-05	0.000449	CcSEcCtD
Danazol—Rash—Vigabatrin—epilepsy syndrome	8.32e-05	0.000449	CcSEcCtD
Danazol—Dizziness—Felbamate—epilepsy syndrome	8.31e-05	0.000448	CcSEcCtD
Danazol—Dermatitis—Vigabatrin—epilepsy syndrome	8.31e-05	0.000448	CcSEcCtD
Danazol—Pruritus—Oxcarbazepine—epilepsy syndrome	8.29e-05	0.000447	CcSEcCtD
Danazol—Convulsion—Pregabalin—epilepsy syndrome	8.29e-05	0.000447	CcSEcCtD
Danazol—Vision blurred—Gabapentin—epilepsy syndrome	8.27e-05	0.000446	CcSEcCtD
Danazol—Headache—Vigabatrin—epilepsy syndrome	8.26e-05	0.000446	CcSEcCtD
Danazol—Hypertension—Pregabalin—epilepsy syndrome	8.26e-05	0.000445	CcSEcCtD
Danazol—Vomiting—Diazepam—epilepsy syndrome	8.26e-05	0.000445	CcSEcCtD
Danazol—Tremor—Gabapentin—epilepsy syndrome	8.22e-05	0.000443	CcSEcCtD
Danazol—Rash—Diazepam—epilepsy syndrome	8.19e-05	0.000442	CcSEcCtD
Danazol—Dermatitis—Diazepam—epilepsy syndrome	8.18e-05	0.000441	CcSEcCtD
Danazol—Visual impairment—Topiramate—epilepsy syndrome	8.17e-05	0.00044	CcSEcCtD
Danazol—Arthralgia—Pregabalin—epilepsy syndrome	8.14e-05	0.000439	CcSEcCtD
Danazol—Dizziness—Zonisamide—epilepsy syndrome	8.14e-05	0.000439	CcSEcCtD
Danazol—Headache—Diazepam—epilepsy syndrome	8.14e-05	0.000439	CcSEcCtD
Danazol—Anxiety—Pregabalin—epilepsy syndrome	8.12e-05	0.000438	CcSEcCtD
Danazol—Asthenia—Carbamazepine—epilepsy syndrome	8.07e-05	0.000435	CcSEcCtD
Danazol—Nausea—Fosphenytoin—epilepsy syndrome	8.04e-05	0.000433	CcSEcCtD
Danazol—Erythema multiforme—Topiramate—epilepsy syndrome	8.01e-05	0.000432	CcSEcCtD
Danazol—Vomiting—Felbamate—epilepsy syndrome	7.99e-05	0.000431	CcSEcCtD
Danazol—Pruritus—Carbamazepine—epilepsy syndrome	7.95e-05	0.000429	CcSEcCtD
Danazol—Rash—Felbamate—epilepsy syndrome	7.93e-05	0.000427	CcSEcCtD
Danazol—Dermatitis—Felbamate—epilepsy syndrome	7.92e-05	0.000427	CcSEcCtD
Danazol—Vertigo—Gabapentin—epilepsy syndrome	7.88e-05	0.000425	CcSEcCtD
Danazol—Headache—Felbamate—epilepsy syndrome	7.87e-05	0.000425	CcSEcCtD
Danazol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.87e-05	0.000424	CcSEcCtD
Danazol—Flushing—Topiramate—epilepsy syndrome	7.87e-05	0.000424	CcSEcCtD
Danazol—Syncope—Gabapentin—epilepsy syndrome	7.87e-05	0.000424	CcSEcCtD
Danazol—Leukopenia—Gabapentin—epilepsy syndrome	7.85e-05	0.000423	CcSEcCtD
Danazol—Dizziness—Clonazepam—epilepsy syndrome	7.84e-05	0.000423	CcSEcCtD
Danazol—Nausea—Vigabatrin—epilepsy syndrome	7.84e-05	0.000423	CcSEcCtD
Danazol—Vomiting—Zonisamide—epilepsy syndrome	7.82e-05	0.000422	CcSEcCtD
Danazol—Oedema—Pregabalin—epilepsy syndrome	7.81e-05	0.000421	CcSEcCtD
Danazol—Asthenia—Lamotrigine—epilepsy syndrome	7.8e-05	0.00042	CcSEcCtD
Danazol—Dizziness—Phenytoin—epilepsy syndrome	7.79e-05	0.00042	CcSEcCtD
Danazol—Rash—Zonisamide—epilepsy syndrome	7.76e-05	0.000418	CcSEcCtD
Danazol—Paraesthesia—Valproic Acid—epilepsy syndrome	7.75e-05	0.000418	CcSEcCtD
Danazol—Palpitations—Gabapentin—epilepsy syndrome	7.75e-05	0.000418	CcSEcCtD
Danazol—Dermatitis—Zonisamide—epilepsy syndrome	7.75e-05	0.000418	CcSEcCtD
Danazol—Dizziness—Oxcarbazepine—epilepsy syndrome	7.75e-05	0.000418	CcSEcCtD
Danazol—Nausea—Diazepam—epilepsy syndrome	7.71e-05	0.000416	CcSEcCtD
Danazol—Loss of consciousness—Gabapentin—epilepsy syndrome	7.71e-05	0.000416	CcSEcCtD
Danazol—Headache—Zonisamide—epilepsy syndrome	7.71e-05	0.000416	CcSEcCtD
Danazol—Pruritus—Lamotrigine—epilepsy syndrome	7.69e-05	0.000415	CcSEcCtD
Danazol—Shock—Pregabalin—epilepsy syndrome	7.68e-05	0.000414	CcSEcCtD
Danazol—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.64e-05	0.000412	CcSEcCtD
Danazol—Tachycardia—Pregabalin—epilepsy syndrome	7.62e-05	0.000411	CcSEcCtD
Danazol—Testosterone—ABCG2—epilepsy syndrome	7.61e-05	0.0249	CrCbGaD
Danazol—Chills—Topiramate—epilepsy syndrome	7.61e-05	0.00041	CcSEcCtD
Danazol—Dyspepsia—Valproic Acid—epilepsy syndrome	7.6e-05	0.00041	CcSEcCtD
Danazol—Convulsion—Gabapentin—epilepsy syndrome	7.6e-05	0.00041	CcSEcCtD
Danazol—Hypertension—Gabapentin—epilepsy syndrome	7.57e-05	0.000408	CcSEcCtD
Danazol—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.55e-05	0.000407	CcSEcCtD
Danazol—Vomiting—Clonazepam—epilepsy syndrome	7.54e-05	0.000407	CcSEcCtD
Danazol—Alopecia—Topiramate—epilepsy syndrome	7.49e-05	0.000404	CcSEcCtD
Danazol—Vomiting—Phenytoin—epilepsy syndrome	7.49e-05	0.000404	CcSEcCtD
Danazol—Rash—Clonazepam—epilepsy syndrome	7.48e-05	0.000403	CcSEcCtD
Danazol—Dermatitis—Clonazepam—epilepsy syndrome	7.47e-05	0.000403	CcSEcCtD
Danazol—Arthralgia—Gabapentin—epilepsy syndrome	7.47e-05	0.000403	CcSEcCtD
Danazol—Nausea—Felbamate—epilepsy syndrome	7.47e-05	0.000403	CcSEcCtD
Danazol—Vomiting—Oxcarbazepine—epilepsy syndrome	7.45e-05	0.000402	CcSEcCtD
Danazol—Fatigue—Valproic Acid—epilepsy syndrome	7.44e-05	0.000401	CcSEcCtD
Danazol—Anxiety—Gabapentin—epilepsy syndrome	7.44e-05	0.000401	CcSEcCtD
Danazol—Dizziness—Carbamazepine—epilepsy syndrome	7.44e-05	0.000401	CcSEcCtD
Danazol—Headache—Clonazepam—epilepsy syndrome	7.43e-05	0.000401	CcSEcCtD
Danazol—Rash—Phenytoin—epilepsy syndrome	7.43e-05	0.0004	CcSEcCtD
Danazol—Dermatitis—Phenytoin—epilepsy syndrome	7.42e-05	0.0004	CcSEcCtD
Danazol—Rash—Oxcarbazepine—epilepsy syndrome	7.39e-05	0.000398	CcSEcCtD
Danazol—Constipation—Valproic Acid—epilepsy syndrome	7.38e-05	0.000398	CcSEcCtD
Danazol—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.38e-05	0.000398	CcSEcCtD
Danazol—Headache—Phenytoin—epilepsy syndrome	7.38e-05	0.000398	CcSEcCtD
Danazol—Headache—Oxcarbazepine—epilepsy syndrome	7.34e-05	0.000396	CcSEcCtD
Danazol—Nausea—Zonisamide—epilepsy syndrome	7.31e-05	0.000394	CcSEcCtD
Danazol—Tension—Topiramate—epilepsy syndrome	7.24e-05	0.00039	CcSEcCtD
Danazol—Dizziness—Lamotrigine—epilepsy syndrome	7.19e-05	0.000387	CcSEcCtD
Danazol—Nervousness—Topiramate—epilepsy syndrome	7.17e-05	0.000386	CcSEcCtD
Danazol—Oedema—Gabapentin—epilepsy syndrome	7.16e-05	0.000386	CcSEcCtD
Danazol—Vomiting—Carbamazepine—epilepsy syndrome	7.15e-05	0.000385	CcSEcCtD
Danazol—Back pain—Topiramate—epilepsy syndrome	7.14e-05	0.000385	CcSEcCtD
Danazol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.11e-05	0.000384	CcSEcCtD
Danazol—Muscle spasms—Topiramate—epilepsy syndrome	7.09e-05	0.000383	CcSEcCtD
Danazol—Rash—Carbamazepine—epilepsy syndrome	7.09e-05	0.000382	CcSEcCtD
Danazol—Dermatitis—Carbamazepine—epilepsy syndrome	7.08e-05	0.000382	CcSEcCtD
Danazol—Nausea—Clonazepam—epilepsy syndrome	7.04e-05	0.00038	CcSEcCtD
Danazol—Headache—Carbamazepine—epilepsy syndrome	7.04e-05	0.00038	CcSEcCtD
Danazol—Shock—Gabapentin—epilepsy syndrome	7.04e-05	0.00038	CcSEcCtD
Danazol—Paraesthesia—Pregabalin—epilepsy syndrome	7.01e-05	0.000378	CcSEcCtD
Danazol—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.01e-05	0.000378	CcSEcCtD
Danazol—Nausea—Phenytoin—epilepsy syndrome	7e-05	0.000377	CcSEcCtD
Danazol—Tachycardia—Gabapentin—epilepsy syndrome	6.99e-05	0.000377	CcSEcCtD
Danazol—Nausea—Oxcarbazepine—epilepsy syndrome	6.96e-05	0.000375	CcSEcCtD
Danazol—Vision blurred—Topiramate—epilepsy syndrome	6.95e-05	0.000375	CcSEcCtD
Danazol—Progesterone—NR3C1—epilepsy syndrome	6.94e-05	0.0227	CrCbGaD
Danazol—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.92e-05	0.000373	CcSEcCtD
Danazol—Tremor—Topiramate—epilepsy syndrome	6.91e-05	0.000373	CcSEcCtD
Danazol—Vomiting—Lamotrigine—epilepsy syndrome	6.91e-05	0.000373	CcSEcCtD
Danazol—Urticaria—Valproic Acid—epilepsy syndrome	6.86e-05	0.00037	CcSEcCtD
Danazol—Rash—Lamotrigine—epilepsy syndrome	6.85e-05	0.000369	CcSEcCtD
Danazol—Dermatitis—Lamotrigine—epilepsy syndrome	6.85e-05	0.000369	CcSEcCtD
Danazol—Body temperature increased—Valproic Acid—epilepsy syndrome	6.83e-05	0.000368	CcSEcCtD
Danazol—Headache—Lamotrigine—epilepsy syndrome	6.81e-05	0.000367	CcSEcCtD
Danazol—Fatigue—Pregabalin—epilepsy syndrome	6.73e-05	0.000363	CcSEcCtD
Danazol—Nausea—Carbamazepine—epilepsy syndrome	6.68e-05	0.00036	CcSEcCtD
Danazol—Constipation—Pregabalin—epilepsy syndrome	6.68e-05	0.00036	CcSEcCtD
Danazol—Vertigo—Topiramate—epilepsy syndrome	6.63e-05	0.000357	CcSEcCtD
Danazol—Syncope—Topiramate—epilepsy syndrome	6.62e-05	0.000357	CcSEcCtD
Danazol—Leukopenia—Topiramate—epilepsy syndrome	6.61e-05	0.000356	CcSEcCtD
Danazol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.52e-05	0.000352	CcSEcCtD
Danazol—Palpitations—Topiramate—epilepsy syndrome	6.52e-05	0.000352	CcSEcCtD
Danazol—Loss of consciousness—Topiramate—epilepsy syndrome	6.49e-05	0.00035	CcSEcCtD
Danazol—Nausea—Lamotrigine—epilepsy syndrome	6.45e-05	0.000348	CcSEcCtD
Danazol—Paraesthesia—Gabapentin—epilepsy syndrome	6.43e-05	0.000347	CcSEcCtD
Danazol—Convulsion—Topiramate—epilepsy syndrome	6.39e-05	0.000345	CcSEcCtD
Danazol—Hypertension—Topiramate—epilepsy syndrome	6.37e-05	0.000344	CcSEcCtD
Danazol—Progesterone—CYP2C19—epilepsy syndrome	6.33e-05	0.0207	CrCbGaD
Danazol—Dyspepsia—Gabapentin—epilepsy syndrome	6.3e-05	0.00034	CcSEcCtD
Danazol—Arthralgia—Topiramate—epilepsy syndrome	6.28e-05	0.000339	CcSEcCtD
Danazol—Anxiety—Topiramate—epilepsy syndrome	6.26e-05	0.000338	CcSEcCtD
Danazol—Urticaria—Pregabalin—epilepsy syndrome	6.2e-05	0.000334	CcSEcCtD
Danazol—Asthenia—Valproic Acid—epilepsy syndrome	6.2e-05	0.000334	CcSEcCtD
Danazol—Fatigue—Gabapentin—epilepsy syndrome	6.17e-05	0.000333	CcSEcCtD
Danazol—Body temperature increased—Pregabalin—epilepsy syndrome	6.17e-05	0.000333	CcSEcCtD
Danazol—Constipation—Gabapentin—epilepsy syndrome	6.12e-05	0.00033	CcSEcCtD
Danazol—Prednisone—ALB—epilepsy syndrome	6.11e-05	0.02	CrCbGaD
Danazol—Pruritus—Valproic Acid—epilepsy syndrome	6.11e-05	0.000329	CcSEcCtD
Danazol—Norethindrone—ALB—epilepsy syndrome	6.03e-05	0.0197	CrCbGaD
Danazol—Oedema—Topiramate—epilepsy syndrome	6.02e-05	0.000325	CcSEcCtD
Danazol—Testosterone—CYP2C19—epilepsy syndrome	5.98e-05	0.0195	CrCbGaD
Danazol—Ethinyl Estradiol—ABCB1—epilepsy syndrome	5.98e-05	0.0195	CrCbGaD
Danazol—Shock—Topiramate—epilepsy syndrome	5.93e-05	0.000319	CcSEcCtD
Danazol—Thrombocytopenia—Topiramate—epilepsy syndrome	5.9e-05	0.000318	CcSEcCtD
Danazol—Tachycardia—Topiramate—epilepsy syndrome	5.88e-05	0.000317	CcSEcCtD
Danazol—Prednisone—ABCB1—epilepsy syndrome	5.83e-05	0.0191	CrCbGaD
Danazol—Hyperhidrosis—Topiramate—epilepsy syndrome	5.82e-05	0.000314	CcSEcCtD
Danazol—Norethindrone—ABCB1—epilepsy syndrome	5.75e-05	0.0188	CrCbGaD
Danazol—Methyltestosterone—ALB—epilepsy syndrome	5.72e-05	0.0187	CrCbGaD
Danazol—Dizziness—Valproic Acid—epilepsy syndrome	5.71e-05	0.000308	CcSEcCtD
Danazol—Urticaria—Gabapentin—epilepsy syndrome	5.69e-05	0.000307	CcSEcCtD
Danazol—Body temperature increased—Gabapentin—epilepsy syndrome	5.66e-05	0.000305	CcSEcCtD
Danazol—Asthenia—Pregabalin—epilepsy syndrome	5.6e-05	0.000302	CcSEcCtD
Danazol—Pruritus—Pregabalin—epilepsy syndrome	5.52e-05	0.000298	CcSEcCtD
Danazol—Vomiting—Valproic Acid—epilepsy syndrome	5.49e-05	0.000296	CcSEcCtD
Danazol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.49e-05	0.000296	CcSEcCtD
Danazol—Rash—Valproic Acid—epilepsy syndrome	5.44e-05	0.000294	CcSEcCtD
Danazol—Dermatitis—Valproic Acid—epilepsy syndrome	5.44e-05	0.000293	CcSEcCtD
Danazol—Headache—Valproic Acid—epilepsy syndrome	5.41e-05	0.000292	CcSEcCtD
Danazol—Paraesthesia—Topiramate—epilepsy syndrome	5.41e-05	0.000292	CcSEcCtD
Danazol—Dyspepsia—Topiramate—epilepsy syndrome	5.3e-05	0.000286	CcSEcCtD
Danazol—Fatigue—Topiramate—epilepsy syndrome	5.19e-05	0.00028	CcSEcCtD
Danazol—Dizziness—Pregabalin—epilepsy syndrome	5.16e-05	0.000278	CcSEcCtD
Danazol—Constipation—Topiramate—epilepsy syndrome	5.15e-05	0.000278	CcSEcCtD
Danazol—Asthenia—Gabapentin—epilepsy syndrome	5.14e-05	0.000277	CcSEcCtD
Danazol—Nausea—Valproic Acid—epilepsy syndrome	5.13e-05	0.000277	CcSEcCtD
Danazol—Pruritus—Gabapentin—epilepsy syndrome	5.06e-05	0.000273	CcSEcCtD
Danazol—Vomiting—Pregabalin—epilepsy syndrome	4.96e-05	0.000268	CcSEcCtD
Danazol—Rash—Pregabalin—epilepsy syndrome	4.92e-05	0.000265	CcSEcCtD
Danazol—Dermatitis—Pregabalin—epilepsy syndrome	4.92e-05	0.000265	CcSEcCtD
Danazol—Headache—Pregabalin—epilepsy syndrome	4.89e-05	0.000264	CcSEcCtD
Danazol—Urticaria—Topiramate—epilepsy syndrome	4.78e-05	0.000258	CcSEcCtD
Danazol—Body temperature increased—Topiramate—epilepsy syndrome	4.76e-05	0.000257	CcSEcCtD
Danazol—Dizziness—Gabapentin—epilepsy syndrome	4.73e-05	0.000255	CcSEcCtD
Danazol—Progesterone—CYP2D6—epilepsy syndrome	4.69e-05	0.0153	CrCbGaD
Danazol—Nausea—Pregabalin—epilepsy syndrome	4.64e-05	0.00025	CcSEcCtD
Danazol—Vomiting—Gabapentin—epilepsy syndrome	4.55e-05	0.000245	CcSEcCtD
Danazol—Rash—Gabapentin—epilepsy syndrome	4.51e-05	0.000243	CcSEcCtD
Danazol—Dermatitis—Gabapentin—epilepsy syndrome	4.51e-05	0.000243	CcSEcCtD
Danazol—Headache—Gabapentin—epilepsy syndrome	4.48e-05	0.000242	CcSEcCtD
Danazol—Asthenia—Topiramate—epilepsy syndrome	4.32e-05	0.000233	CcSEcCtD
Danazol—Pruritus—Topiramate—epilepsy syndrome	4.26e-05	0.00023	CcSEcCtD
Danazol—Nausea—Gabapentin—epilepsy syndrome	4.25e-05	0.000229	CcSEcCtD
Danazol—Hydrocortisone—ABCB1—epilepsy syndrome	4.11e-05	0.0134	CrCbGaD
Danazol—Dizziness—Topiramate—epilepsy syndrome	3.98e-05	0.000215	CcSEcCtD
Danazol—Vomiting—Topiramate—epilepsy syndrome	3.83e-05	0.000206	CcSEcCtD
Danazol—Rash—Topiramate—epilepsy syndrome	3.8e-05	0.000205	CcSEcCtD
Danazol—Dermatitis—Topiramate—epilepsy syndrome	3.79e-05	0.000205	CcSEcCtD
Danazol—Headache—Topiramate—epilepsy syndrome	3.77e-05	0.000203	CcSEcCtD
Danazol—Nausea—Topiramate—epilepsy syndrome	3.58e-05	0.000193	CcSEcCtD
Danazol—Progesterone—ABCB1—epilepsy syndrome	3.35e-05	0.0109	CrCbGaD
Danazol—Testosterone—ALB—epilepsy syndrome	3.32e-05	0.0108	CrCbGaD
Danazol—Testosterone—ABCB1—epilepsy syndrome	3.17e-05	0.0103	CrCbGaD
Danazol—PGR—Signaling Pathways—NTRK2—epilepsy syndrome	1.07e-05	8.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SST—epilepsy syndrome	1.07e-05	8.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR2—epilepsy syndrome	1.07e-05	8.83e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HSPB1—epilepsy syndrome	1.07e-05	8.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PGF—epilepsy syndrome	1.07e-05	8.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRM8—epilepsy syndrome	1.07e-05	8.79e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KDR—epilepsy syndrome	1.07e-05	8.79e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DUSP6—epilepsy syndrome	1.06e-05	8.75e-05	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.06e-05	8.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRA2A—epilepsy syndrome	1.05e-05	8.64e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLAT—epilepsy syndrome	1.05e-05	8.6e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PRKCB—epilepsy syndrome	1.03e-05	8.46e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6ST—epilepsy syndrome	1.02e-05	8.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—OPRD1—epilepsy syndrome	1.02e-05	8.39e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNAO1—epilepsy syndrome	1.02e-05	8.39e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TSC2—epilepsy syndrome	1.02e-05	8.39e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AGT—epilepsy syndrome	1.02e-05	8.38e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BDKRB2—epilepsy syndrome	1.01e-05	8.3e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL12—epilepsy syndrome	1.01e-05	8.3e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—epilepsy syndrome	9.98e-06	8.21e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUNB—epilepsy syndrome	9.91e-06	8.15e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CNR1—epilepsy syndrome	9.91e-06	8.15e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	9.9e-06	8.14e-05	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	9.87e-06	8.12e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLCB1—epilepsy syndrome	9.87e-06	8.12e-05	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—epilepsy syndrome	9.82e-06	8.08e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR7—epilepsy syndrome	9.78e-06	8.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CHRM1—epilepsy syndrome	9.78e-06	8.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDYN—epilepsy syndrome	9.78e-06	8.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRM1—epilepsy syndrome	9.78e-06	8.04e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—epilepsy syndrome	9.78e-06	8.04e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR7—epilepsy syndrome	9.67e-06	7.95e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	9.65e-06	7.93e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	9.59e-06	7.89e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.52e-06	7.83e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PRKCB—epilepsy syndrome	9.41e-06	7.74e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HBEGF—epilepsy syndrome	9.38e-06	7.72e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6ST—epilepsy syndrome	9.37e-06	7.71e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—POMC—epilepsy syndrome	9.37e-06	7.71e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—SIRT1—epilepsy syndrome	9.35e-06	7.69e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—VDR—epilepsy syndrome	9.21e-06	7.58e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT3—epilepsy syndrome	9.21e-06	7.58e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GAL—epilepsy syndrome	9.19e-06	7.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GFAP—epilepsy syndrome	9.19e-06	7.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRM5—epilepsy syndrome	9.09e-06	7.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CHRM3—epilepsy syndrome	9.09e-06	7.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP2—epilepsy syndrome	9.09e-06	7.48e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADAM10—epilepsy syndrome	9e-06	7.4e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—JUNB—epilepsy syndrome	8.94e-06	7.36e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—H2AFX—epilepsy syndrome	8.74e-06	7.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CX3CR1—epilepsy syndrome	8.72e-06	7.17e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.68e-06	7.14e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	8.65e-06	7.12e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—POMC—epilepsy syndrome	8.57e-06	7.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BDKRB1—epilepsy syndrome	8.55e-06	7.03e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CHRM2—epilepsy syndrome	8.55e-06	7.03e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CX3CL1—epilepsy syndrome	8.55e-06	7.03e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.53e-06	7.02e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.53e-06	7.02e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	8.53e-06	7.02e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.53e-06	7.02e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.53e-06	7.02e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.53e-06	7.02e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—S100B—epilepsy syndrome	8.51e-06	7e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—YWHAZ—epilepsy syndrome	8.43e-06	6.93e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SOCS3—epilepsy syndrome	8.42e-06	6.93e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDC42—epilepsy syndrome	8.4e-06	6.91e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL2—epilepsy syndrome	8.39e-06	6.9e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GABBR1—epilepsy syndrome	8.31e-06	6.84e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—NR3C1—epilepsy syndrome	8.29e-06	6.82e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGF2—epilepsy syndrome	8.29e-06	6.82e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	8.24e-06	6.77e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—BCHE—epilepsy syndrome	8.2e-06	6.75e-05	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.18e-06	6.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AVP—epilepsy syndrome	8.14e-06	6.69e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRH3—epilepsy syndrome	7.97e-06	6.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—OPRM1—epilepsy syndrome	7.85e-06	6.45e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	7.83e-06	6.44e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.81e-06	6.42e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.81e-06	6.42e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.81e-06	6.42e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.81e-06	6.42e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	7.74e-06	6.37e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TH—epilepsy syndrome	7.71e-06	6.34e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RELA—epilepsy syndrome	7.7e-06	6.33e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HES1—epilepsy syndrome	7.69e-06	6.33e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.59e-06	6.24e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGF2—epilepsy syndrome	7.58e-06	6.24e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MTOR—epilepsy syndrome	7.55e-06	6.21e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FYN—epilepsy syndrome	7.48e-06	6.15e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—H2AFX—epilepsy syndrome	7.45e-06	6.13e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MEF2C—epilepsy syndrome	7.44e-06	6.12e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR3—epilepsy syndrome	7.41e-06	6.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.26e-06	5.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.26e-06	5.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.23e-06	5.95e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NPY—epilepsy syndrome	7.22e-06	5.94e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ATP2A2—epilepsy syndrome	7.22e-06	5.94e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SIRT1—epilepsy syndrome	7.2e-06	5.92e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—YWHAZ—epilepsy syndrome	7.19e-06	5.92e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NGF—epilepsy syndrome	7.11e-06	5.85e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—VDR—epilepsy syndrome	7.1e-06	5.84e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RELA—epilepsy syndrome	7.04e-06	5.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL2—epilepsy syndrome	6.97e-06	5.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HSPB1—epilepsy syndrome	6.97e-06	5.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CRH—epilepsy syndrome	6.97e-06	5.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL3—epilepsy syndrome	6.97e-06	5.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—OXT—epilepsy syndrome	6.97e-06	5.73e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—epilepsy syndrome	6.94e-06	5.71e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR5—epilepsy syndrome	6.92e-06	5.69e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MTOR—epilepsy syndrome	6.9e-06	5.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.82e-06	5.61e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR2A—epilepsy syndrome	6.77e-06	5.57e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JUN—epilepsy syndrome	6.74e-06	5.54e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—H2AFX—epilepsy syndrome	6.73e-06	5.53e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—epilepsy syndrome	6.56e-06	5.39e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—YWHAZ—epilepsy syndrome	6.49e-06	5.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTK2B—epilepsy syndrome	6.48e-06	5.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC1—epilepsy syndrome	6.48e-06	5.33e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.47e-06	5.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.47e-06	5.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.47e-06	5.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.47e-06	5.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.47e-06	5.32e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	6.44e-06	5.29e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSC2—epilepsy syndrome	6.43e-06	5.29e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AGT—epilepsy syndrome	6.42e-06	5.28e-05	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—epilepsy syndrome	6.41e-06	5.27e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR3C1—epilepsy syndrome	6.39e-06	5.25e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—epilepsy syndrome	6.36e-06	5.23e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAT—epilepsy syndrome	6.35e-06	5.22e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—epilepsy syndrome	6.35e-06	5.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR2—epilepsy syndrome	6.3e-06	5.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK2—epilepsy syndrome	6.3e-06	5.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SST—epilepsy syndrome	6.3e-06	5.18e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—epilepsy syndrome	6.29e-06	5.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DUSP6—epilepsy syndrome	6.25e-06	5.14e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	6.18e-06	5.08e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.17e-06	5.07e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—epilepsy syndrome	6.17e-06	5.07e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—epilepsy syndrome	6.17e-06	5.07e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLAT—epilepsy syndrome	6.14e-06	5.05e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—epilepsy syndrome	6.05e-06	4.97e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—epilepsy syndrome	6e-06	4.93e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKCB—epilepsy syndrome	5.94e-06	4.88e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BDKRB2—epilepsy syndrome	5.92e-06	4.87e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL12—epilepsy syndrome	5.92e-06	4.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.92e-06	4.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.92e-06	4.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.92e-06	4.87e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6ST—epilepsy syndrome	5.91e-06	4.86e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—epilepsy syndrome	5.89e-06	4.84e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—epilepsy syndrome	5.82e-06	4.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CNR1—epilepsy syndrome	5.81e-06	4.78e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUNB—epilepsy syndrome	5.81e-06	4.78e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLCB1—epilepsy syndrome	5.79e-06	4.77e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPX1—epilepsy syndrome	5.74e-06	4.72e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.69e-06	4.68e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR7—epilepsy syndrome	5.67e-06	4.67e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—epilepsy syndrome	5.53e-06	4.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HBEGF—epilepsy syndrome	5.51e-06	4.53e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.5e-06	4.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.5e-06	4.52e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—epilepsy syndrome	5.41e-06	4.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT3—epilepsy syndrome	5.41e-06	4.45e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—epilepsy syndrome	5.39e-06	4.43e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—epilepsy syndrome	5.29e-06	4.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADAM10—epilepsy syndrome	5.28e-06	4.34e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.17e-06	4.25e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AGT—epilepsy syndrome	5.04e-06	4.14e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.03e-06	4.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—S100B—epilepsy syndrome	4.99e-06	4.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SOCS3—epilepsy syndrome	4.94e-06	4.07e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—epilepsy syndrome	4.93e-06	4.06e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDC42—epilepsy syndrome	4.93e-06	4.06e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.9e-06	4.03e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.9e-06	4.03e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF2—epilepsy syndrome	4.78e-06	3.93e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AVP—epilepsy syndrome	4.78e-06	3.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.68e-06	3.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.68e-06	3.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.58e-06	3.76e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HES1—epilepsy syndrome	4.52e-06	3.71e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.48e-06	3.69e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RELA—epilepsy syndrome	4.44e-06	3.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.4e-06	3.62e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FYN—epilepsy syndrome	4.39e-06	3.61e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	4.38e-06	3.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	4.37e-06	3.59e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTOR—epilepsy syndrome	4.35e-06	3.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.32e-06	3.55e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—epilepsy syndrome	4.24e-06	3.49e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.22e-06	3.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGF—epilepsy syndrome	4.17e-06	3.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	4.06e-06	3.34e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.04e-06	3.32e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—epilepsy syndrome	4e-06	3.29e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	3.97e-06	3.27e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.92e-06	3.22e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—epilepsy syndrome	3.89e-06	3.2e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—epilepsy syndrome	3.86e-06	3.18e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—epilepsy syndrome	3.78e-06	3.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	3.77e-06	3.1e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGT—epilepsy syndrome	3.77e-06	3.1e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—epilepsy syndrome	3.76e-06	3.09e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—epilepsy syndrome	3.69e-06	3.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—epilepsy syndrome	3.62e-06	2.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.54e-06	2.91e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.54e-06	2.91e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—epilepsy syndrome	3.49e-06	2.87e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	3.48e-06	2.87e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	3.47e-06	2.85e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—epilepsy syndrome	3.44e-06	2.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—epilepsy syndrome	3.4e-06	2.79e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	3.38e-06	2.78e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—epilepsy syndrome	3.33e-06	2.74e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—epilepsy syndrome	3.17e-06	2.61e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	3.1e-06	2.55e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.89e-06	2.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.82e-06	2.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	2.81e-06	2.31e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.8e-06	2.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RELA—epilepsy syndrome	2.6e-06	2.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	2.55e-06	2.1e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—epilepsy syndrome	2.54e-06	2.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.53e-06	2.08e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.4e-06	1.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.39e-06	1.97e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	2.35e-06	1.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.28e-06	1.88e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—epilepsy syndrome	2.28e-06	1.88e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.26e-06	1.86e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TH—epilepsy syndrome	2.25e-06	1.85e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	2.22e-06	1.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—epilepsy syndrome	2.17e-06	1.78e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—epilepsy syndrome	2.05e-06	1.68e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	1.99e-06	1.64e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—epilepsy syndrome	1.96e-06	1.61e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.88e-06	1.54e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.85e-06	1.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.8e-06	1.48e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—epilepsy syndrome	1.7e-06	1.4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.68e-06	1.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.47e-06	1.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.44e-06	1.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	1.27e-06	1.05e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.24e-06	1.02e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.13e-06	9.28e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.87e-07	8.12e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.96e-07	4.08e-06	CbGpPWpGaD
